Squarepoint Ops LLC Vbi Vaccines Inc Transaction History

Squarepoint Ops LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $23,401 - $750,133	-32,057 Reduced 33.03%	64,985 $46,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $33,019 - $90,554	50,030 Added 106.42%	97,042 $78,000
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $23,580 - $45,860	-18,567 Reduced 28.31%	47,012 $78,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $82,077 - $119,587	37,139 Added 130.59%	65,579 $153,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $443,133 - $588,734	-158,262 Reduced 84.77%	28,440 $88,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $381,498 - $609,520	146,168 Added 360.61%	186,702 $625,000
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $35,958 - $53,382	-12,357 Reduced 23.36%	40,534 $126,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $689,085 - $1.12 Million	-320,505 Reduced 85.84%	52,891 $145,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $740,335 - $1.65 Million	267,269 Added 251.84%	373,396 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $92,330 - $332,177	106,127 New	106,127 $329,000
Q4 2019 Feb 14, 2020	SELL	$0.48 - $1.38 $217,491 - $625,289	-453,108 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $212,960 - $475,763	453,108 New	453,108 $214,000
Q1 2019 May 15, 2019	SELL	$1.54 - $2.01 $22,633 - $29,540	-14,697 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.22 - $2.41 $62,517 - $123,498	-51,244 Reduced 77.71%	14,697 $24,000
Q3 2018 Nov 14, 2018	BUY	$1.75 - $2.93 $88,320 - $147,874	50,469 Added 326.2%	65,941 $160,000
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $42,548 - $59,567	15,472 New	15,472 $43,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.